HMGB1 and hepatocellular carcinoma: Glycyrrhizin, a phytochemical that directly inhibits HMGB1 [60], is widely used for the treatment of liver disease in Asia, and there are indications that glycyrrhizin can reduce HCC development in certain patient subsets [61].